As Fig. 2D shows, the number of Lin-CD34+CD38+ HPCs was dramatically depressed in the bone marrow of myeloma patients compared with that of healthy patients (0.39% ± 0.07% vs. 0.98% ± 0.14%, p = 0.0002). This evidence concerns the gene CD38 and plasma cell myeloma.